113 related articles for article (PubMed ID: 10437252)
1. The effects of Chinese drugs for supporting healthy energy and removing blood stasis on postoperative metastasis of gastric carcinoma and ornithine decarboxylase.
Ping B
J Tradit Chin Med; 1998 Mar; 18(1):3-6. PubMed ID: 10437252
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
3. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
Yano M; Tsujinaka T; Shiozaki H; Inoue M; Doki Y; Taniguchi M; Murata A; Monden M
Gan To Kagaku Ryoho; 1998 Jan; 25(1):139-42. PubMed ID: 9464342
[No Abstract] [Full Text] [Related]
4. [Concurrent low-dose cisplatin/5-FU chemotherapy and radiation for the recurrent gastric carcinoma--case reports].
Gohongi T; Iida H; Nakai R; Gunji N; Orii K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):989-92. PubMed ID: 16835494
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study on post-operative metastasis prevention of progressive stage of gastric cancer by weichang'an].
Yang JK; Zhen J; Shen KP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):580-2. PubMed ID: 14503054
[TBL] [Abstract][Full Text] [Related]
6. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on early use of Chinese medicinal herbs and chemotherapy after operation of gastric cancer].
Yu QS; Zhang FZ; Tang XR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Aug; 15(8):459-61. PubMed ID: 8580690
[TBL] [Abstract][Full Text] [Related]
8. [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Mihara K; Yamashiro N; Nishiya S; Kemmochi T; Ito Y; Egawa T; Nagashima A
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2358-60. PubMed ID: 25731522
[TBL] [Abstract][Full Text] [Related]
9. Decision-making in surgery: the management of gastric carcinoma.
Huang J; Goddard L; Thomas PA
Br J Hosp Med; 1997 May 21-Jun 3; 57(10):502-4. PubMed ID: 9329999
[No Abstract] [Full Text] [Related]
10. [Successful treatment of advanced gastric cancer (Borrmann 1 type) with FTP chemotherapy after reduction surgery].
Nomura N; Yamada A; Saitou F; Tsuzawa T; Yamashita I; Sakakibara T; Shimizu T; Sakamoto T; Karaki Y; Tazawa K
Gan To Kagaku Ryoho; 1994 May; 21(6):865-8. PubMed ID: 8185346
[TBL] [Abstract][Full Text] [Related]
11. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with 5-FU modulated by low-dose CDDP for advanced cancers and recurrent cases of metastasis].
Shinkai K; Kida H; Hisano H; Shibasaki S; Yano H; Nomura M
Gan To Kagaku Ryoho; 1999 Feb; 26(3):329-32. PubMed ID: 10065096
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals].
Wang GT
Zhong Xi Yi Jie He Za Zhi; 1990 Dec; 10(12):712-6, 707. PubMed ID: 2292115
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of gastric carcinoma in III stage].
Lin C; Zhu X; Chai Z
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):548-50. PubMed ID: 8731875
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
16. [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Murakami M; Morikawa A; Okabe R; Hayashi K; Miyazawa K; Iijima S; Ozaki K; Suzuki A; Koyama Y; Sugiyama A
Gan To Kagaku Ryoho; 2002 May; 29(5):767-70. PubMed ID: 12040682
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Okabe H; Hata H; Ueda S; Zaima M; Tokuka A; Yoshimura T; Ota S; Kinjo Y; Yoshimura K; Sakai Y;
J Surg Oncol; 2016 Jan; 113(1):36-41. PubMed ID: 26604064
[TBL] [Abstract][Full Text] [Related]
18. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Br J Cancer; 1999 Oct; 81(3):484-9. PubMed ID: 10507774
[TBL] [Abstract][Full Text] [Related]
19. [A case of advanced gastric carcinoma with liver metastasis with no recurrence and long survival by means of surgery and postoperative chemotherapy].
Koyasaki N; Matsumura A; Kamata T; Kanno M
Gan To Kagaku Ryoho; 2002 Apr; 29(4):611-4. PubMed ID: 11977549
[TBL] [Abstract][Full Text] [Related]
20. Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
Kim JS; Kim MA; Oh DY; Lee SH; Kim DW; Im SA; Kim WH; Yang HK; Heo DS; Bang YJ; Lee KU; Kim TY; Kim TM; Kim NK; Choe KJ
Jpn J Clin Oncol; 2011 Feb; 41(2):245-52. PubMed ID: 21106599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
